Bracco Diagnostics has entered into a partnership with CardioNavix in an effort to increase access to cardiac PET imaging.
The collaboration, called Bracco Mobile Isotope Service, will help more community hospitals, physician practices, and outpatient centers to have access to cardiac PET, the company said. It features on-demand delivery, which should make Bracco's CardioGen-82 radiopharmaceutical more easily available to smaller sites, according to the firm.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
